| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/J.AJPATH.2015.12.017 |
| P8608 | Fatcat ID | release_2nomoratwretzdiau2iiyvnnpq |
| P932 | PMC publication ID | 4861760 |
| P698 | PubMed publication ID | 26948424 |
| P50 | author | Arti V Shinde | Q114513566 |
| Vikrant Rai | Q42684496 | ||
| Nikolaos G Frangogiannis | Q56899107 | ||
| Ilaria Russo | Q57345537 | ||
| P2093 | author name string | Ya Su | |
| Amit Saxena | |||
| Claudio Humeres | |||
| Waqas Hanif | |||
| Olga Frunza | |||
| P2860 | cites work | Expression of galectin-3 modulates T-cell growth and apoptosis | Q24309392 |
| Galectin-3 regulates myofibroblast activation and hepatic fibrosis | Q24546358 | ||
| Regulation of transforming growth factor-β1-driven lung fibrosis by galectin-3 | Q24624887 | ||
| Galectin-3 expression and secretion links macrophages to the promotion of renal fibrosis | Q24649584 | ||
| CXCR3-independent actions of the CXC chemokine CXCL10 in the infarcted myocardium and in isolated cardiac fibroblasts are mediated through proteoglycans | Q34106221 | ||
| Genetic and pharmacological inhibition of galectin-3 prevents cardiac remodeling by interfering with myocardial fibrogenesis | Q34316944 | ||
| Regulatory T cells are recruited in the infarcted mouse myocardium and may modulate fibroblast phenotype and function | Q34356195 | ||
| Galectin-3 marks activated macrophages in failure-prone hypertrophied hearts and contributes to cardiac dysfunction | Q34364121 | ||
| Utility of amino-terminal pro-brain natriuretic peptide, galectin-3, and apelin for the evaluation of patients with acute heart failure | Q34566520 | ||
| The regulation of inflammation by galectin-3. | Q34991925 | ||
| Galectin-3: a novel mediator of heart failure development and progression | Q34995162 | ||
| Endogenous thrombospondin 1 protects the pressure-overloaded myocardium by modulating fibroblast phenotype and matrix metabolism | Q35421651 | ||
| Thrombospondin-1 induction in the diabetic myocardium stabilizes the cardiac matrix in addition to promoting vascular rarefaction through angiopoietin-2 upregulation | Q35534242 | ||
| The Mac-2 antigen is a galactose-specific lectin that binds IgE. | Q35596399 | ||
| Galectin-3 expression and subcellular localization in senescent human fibroblasts | Q73492361 | ||
| Galectin-3: a novel antiapoptotic molecule with a functional BH1 (NWGR) domain of Bcl-2 family | Q73931768 | ||
| Role of vascular endothelial growth factor-A in development of abdominal aortic aneurysm | Q83706455 | ||
| Galectin-3 in ambulatory patients with heart failure: results from the HF-ACTION study | Q35680958 | ||
| Expression and function of galectin-3, a beta-galactoside-binding lectin, in human monocytes and macrophages. | Q35798551 | ||
| Targeted disruption of the galectin-3 gene results in attenuated peritoneal inflammatory responses. | Q35809897 | ||
| Smad3 Signaling Promotes Fibrosis While Preserving Cardiac and Aortic Geometry in Obese Diabetic Mice | Q35883067 | ||
| Galectin-3, a marker of cardiac fibrosis, predicts incident heart failure in the community | Q36439679 | ||
| Role of galectin-3 in classical and alternative macrophage activation in the liver following acetaminophen intoxication | Q36456913 | ||
| Systematic characterization of myocardial inflammation, repair, and remodeling in a mouse model of reperfused myocardial infarction | Q37047650 | ||
| Transdifferentiation of mouse aortic smooth muscle cells to a macrophage-like state after cholesterol loading | Q37089500 | ||
| IL-1 induces proinflammatory leukocyte infiltration and regulates fibroblast phenotype in the infarcted myocardium. | Q37293969 | ||
| Recommendations for the evaluation of left ventricular diastolic function by echocardiography | Q37383745 | ||
| Characterization of the inflammatory and fibrotic response in a mouse model of cardiac pressure overload. | Q37434655 | ||
| The role of IL-1 in the pathogenesis of heart disease. | Q37460270 | ||
| Transforming growth factor (TGF)-β signaling in cardiac remodeling. | Q37808014 | ||
| Galectin-3: a modifiable risk factor in heart failure | Q38208784 | ||
| Origin and functions of tissue macrophages. | Q38230878 | ||
| Functions of galectin-3 and its role in fibrotic diseases | Q38246458 | ||
| Galectin-1 and galectin-3 in fetal development of bovine respiratory and digestive tracts. Comparison of cell type-specific expression profiles and subcellular localization. | Q38292645 | ||
| Galectin-3 stimulates cell proliferation | Q38330513 | ||
| Galectin-3 blockade inhibits cardiac inflammation and fibrosis in experimental hyperaldosteronism and hypertension | Q38387964 | ||
| Regulation of alternative macrophage activation by galectin-3. | Q40016366 | ||
| The impact of galectin-3 inhibition on aldosterone-induced cardiac and renal injuries. | Q41744993 | ||
| Smad3 signaling critically regulates fibroblast phenotype and function in healing myocardial infarction | Q41769718 | ||
| Granulocyte macrophage colony stimulating factor produced in lesioned peripheral nerves induces the up-regulation of cell surface expression of MAC-2 by macrophages and Schwann cells | Q41922181 | ||
| Galectin-3 is induced in rheumatoid arthritis synovial fibroblasts after adhesion to cartilage oligomeric matrix protein. | Q42086638 | ||
| Induction of the CXC chemokine interferon-gamma-inducible protein 10 regulates the reparative response following myocardial infarction. | Q42278450 | ||
| Intranuclear distribution of galectin-3 in mouse 3T3 fibroblasts: comparative analyses by immunofluorescence and immunoelectron microscopy | Q42824084 | ||
| Galectin-3 is an independent marker for ventricular remodeling and mortality in patients with chronic heart failure | Q44426645 | ||
| Galectin-1 controls cardiac inflammation and ventricular remodeling during acute myocardial infarction | Q44762410 | ||
| Galectin-3 is a negative regulator of lipopolysaccharide-mediated inflammation | Q46442221 | ||
| Myocardial remodeling in hypertensive Ren-2 transgenic rats | Q46720922 | ||
| Galectin-3 functions as an adhesion molecule to support eosinophil rolling and adhesion under conditions of flow. | Q46891774 | ||
| Role of colony-stimulating factor-1 in macrophage activation in tumor-bearing mice | Q53995738 | ||
| Galectin-3 Mediates Aldosterone-Induced Vascular Fibrosis | Q61187743 | ||
| Expression of galectins on microvessel endothelial cells and their involvement in tumour cell adhesion | Q72110806 | ||
| Regulation of secretion and surface expression of Mac-2, a galactoside-binding protein of macrophages | Q72772895 | ||
| P433 | issue | 5 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 1114-1127 | |
| P577 | publication date | 2016-03-03 | |
| P1433 | published in | The American Journal of Pathology | Q4744259 |
| P1476 | title | Myocardial Galectin-3 Expression Is Associated with Remodeling of the Pressure-Overloaded Heart and May Delay the Hypertrophic Response without Affecting Survival, Dysfunction, and Cardiac Fibrosis | |
| P478 | volume | 186 |
| Q90069019 | Association between Galectin-3 levels within central and peripheral venous blood, and adverse left ventricular remodelling after first acute myocardial infarction |
| Q88007741 | Authors' Reply |
| Q64328935 | Cystatin C and galectin-3 as therapeutic targets in heart failure |
| Q90585459 | Disconnect between Fibrotic Response and Right Ventricular Dysfunction |
| Q50542706 | Fibrosis and Fibrotic Gene Expression in Pediatric and Adult Patients With Idiopathic Dilated Cardiomyopathy. |
| Q87936770 | Galectin-3 in the pathogenesis of heart failure: a causative mediator or simply a biomarker? |
| Q49670112 | Galectin-3 regulation of wound healing and fibrotic processes: insights for chronic skin wound therapeutics |
| Q51816888 | Left atrial remodeling, hypertrophy, and fibrosis in mouse models of heart failure. |
| Q55230733 | Mechanisms responsible for increased circulating levels of galectin-3 in cardiomyopathy and heart failure. |
| Q90692343 | Moving galectin-3 closer to the goal line |
| Q91594685 | Myocardial Injury After Ischemia/Reperfusion Is Attenuated By Pharmacological Galectin-3 Inhibition |
| Q64061682 | Perindopril and a Galectin-3 Inhibitor Improve Ischemic Heart Failure in Rabbits by Reducing Gal-3 Expression and Myocardial Fibrosis |
| Q87883713 | Pharmacologic inhibition of the enzymatic effects of tissue transglutaminase reduces cardiac fibrosis and attenuates cardiomyocyte hypertrophy following pressure overload |
| Q90729459 | Post-operative acute kidney injury is associated with a biomarker of acute brain injury after paediatric cardiac surgery |
| Q99587532 | Targeting cardiac fibrosis in heart failure with preserved ejection fraction: mirage or miracle? |
| Q47171988 | The role of α-smooth muscle actin in fibroblast-mediated matrix contraction and remodeling. |
| Q54785371 | Tissue transglutaminase induction in the pressure-overloaded myocardium regulates matrix remodelling. |
Search more.